Table 6

Health related quality of evaluated life (HRQoL) by Short-Form 36 (SF-36) at baseline and follow-up in patients grouped according to their answer to the statement at follow-up that 'The expectations I had regarding my treatment have been met'

 Completely disagree Baseline n=48 Follow-up n=44 Agree partially Baseline n=79 Follow-up n=76 Agree almost entirely Baseline n=83 Follow-up n=82 Agree entirely Baseline n=272 Follow-up n=265 Correlation of baseline values between the four alternatives from completely disagree to agree entirely† Correlation of changes from baseline to follow-up between the four alternatives from completely disagree to agree entirely # Mean (SD) Mean (SD) Mean (SD) Mean (SD) p value rs p value PF Baseline Follow-up Change 50.1 (25.7) 51.4 (25.5) 0.000 (10.7) 51.7 (21.4) 56.2 (23.7) 3.73 (18.2) 63.0 (23.6) 71.5 (24.1) 8.75 (19.8)*** 65.2 (20.9) 77.0 (19.9) 11.8 (19.2)*** rs=0.24 <0.0001 rs=0.36 p<0.0001 rs=0.22 <0.0001 RP Baseline Follow-up Change 27.3 (35.7) 26.7 (37.9) 0.610 (32.4) 24.7 (35.2) 28.2 (36.3) 4.51 (40.8) 43.4 (40.6) 55.9 (40.4) 11.8 (37.1)** 42.8 (41.1) 64.2 (40.7) 21.1 (47.3)*** rs=0.15 0.001 rs=0.34 p<0.0001 rs=0.18 0.0001 BP Baseline Follow-up Change 45.3 (25.1) 47.6 (27.4) 0.825 (20.6) 46.5 (19.9) 55.7 (23.3) 9.21 (26.2)** 60.1 (25.0) 68.4 (25.9) 8.49 (23.3)** 58.7 (25.1) 76.1 (26.2) 16.9 (28.0)*** rs=0.18 0.0001 rs=0.36 p<0.0001 rs=0.19 <0.0001 GH Baseline Follow-up Change 49.1 (20.0) 43.8 (17.5) −4.30 (13.6) 49.5 (18.4) 46.0 (19.8) −3.65 (19.2) 57.3 (17.5) 57.9 (20.5) 0.416 (15.9) 59.0 (20.8) 68.0 (22.0) 8.70 (20.1)*** rs=0.20 <0.0001 rs=0.42 p<0.0001 rs=0.28 <0.0001 VT Baseline Follow-up Change 37.7 (23.2) 41.6 (21.3) 1.46 (20.3) 41.2 (18.1) 43.7 (19.3) 2.91 (19.8) 50.8 (22.2) 56.5 (21.5) 5.78 (17.4)** 50.5 (23.7) 63.5 (24.1) 12.8 (23.9)*** rs=0.17 0.0003 rs=0.36 p<0.0001 rs=0.21 <0.0001 SF Baseline Follow-up Change 65.0 (29.7) 72.7 (26.3) 5.95 (22.5) 64.7 (26.2_) 67.9 (25.3) 1.86 (26.1) 72.5 (23.3) 77.0 (20.8) 4.81 (20.1) 76.5 (23.2) 85.3 (21.7) 8.78 (24.4)*** rs=0.18 0.0001 rs=0.30 p<0.0001 rs=0.10 0.041 RE Baseline Follow-up Change 56.5 (45.0) 53.6 (45.8) −2.96 (44.9) 54.7 (42.1) 47.2 (43.7) −4.84 (53.8) 64.1 (43.9) 68.3 (38.8) 5.64 (42.7) 59.4 (41.3) 75.2 (37.8) 16.1 (47.2)*** rs=0.02 0.70 rs=0.25 p<0.0001 rs=0.18 0.0001 MH Baseline Follow-up Change 64.2 (23.7) 69.9 (22.6) 2.44 (16.8) 65.2 (19.6) 66.4 (19.6) 1.18 (17.0) 70.1 (18.0) 71.5 (18.8) 1.28 (15.8) 71.8 (19.4) 80.2 (18.7) 8.19 (18.3)*** rs=0.13 0.004 rs=0.29 p<0.0001 rs=0.19 <0.0001
• For comparison between baseline and follow-up Wilcoxon signed-ranks test were used and significance set at *p<0.05, **p<0.01 and ***p<0.001.

• For comparison between the four alternatives rs= Spearmen’s rank correlation test were used for continuous variables.

• B, baseline; BP, bodily pain; FU, follow-up; GH, general health; MH, mental health; PF, physical function; RE, role emotional; RP, role physical; SF, social function.